These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 15090933)
1. Effect of riluzole on dyskinesia and duration of the on state in Parkinson disease patients: a double-blind, placebo-controlled pilot study. Braz CA; Borges V; Ferraz HB Clin Neuropharmacol; 2004; 27(1):25-9. PubMed ID: 15090933 [TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease. Jankovic J; Hunter C Parkinsonism Relat Disord; 2002 Mar; 8(4):271-6. PubMed ID: 12039422 [TBL] [Abstract][Full Text] [Related]
3. Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease. Fox SH; Metman LV; Nutt JG; Brodsky M; Factor SA; Lang AE; Pope LE; Knowles N; Siffert J Mov Disord; 2017 Jun; 32(6):893-903. PubMed ID: 28370447 [TBL] [Abstract][Full Text] [Related]
10. Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Verhagen Metman L; Del Dotto P; van den Munckhof P; Fang J; Mouradian MM; Chase TN Neurology; 1998 May; 50(5):1323-6. PubMed ID: 9595981 [TBL] [Abstract][Full Text] [Related]
12. Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone. Rascol O; Barone P; Behari M; Emre M; Giladi N; Olanow CW; Ruzicka E; Bibbiani F; Squillacote D; Patten A; Tolosa E Clin Neuropharmacol; 2012; 35(1):15-20. PubMed ID: 22222634 [TBL] [Abstract][Full Text] [Related]
13. Drug treatments of levodopa-induced dyskinesias. Vale S Lancet; 1999 Aug; 354(9177):511. PubMed ID: 10465195 [No Abstract] [Full Text] [Related]
14. Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease. Van Blercom N; Lasa A; Verger K; Masramón X; Sastre VM; Linazasoro G Clin Neuropharmacol; 2004; 27(3):124-8. PubMed ID: 15190235 [TBL] [Abstract][Full Text] [Related]
15. A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia. Trenkwalder C; Berg D; Rascol O; Eggert K; Ceballos-Baumann A; Corvol JC; Storch A; Zhang L; Azulay JP; Broussolle E; Defebvre L; Geny C; Gostkowski M; Stocchi F; Tranchant C; Derkinderen P; Durif F; Espay AJ; Feigin A; Houeto JL; Schwarz J; Di Paolo T; Feuerbach D; Hockey HU; Jaeger J; Jakab A; Johns D; Linazasoro G; Maruff P; Rozenberg I; Sovago J; Weiss M; Gomez-Mancilla B Mov Disord; 2016 Jul; 31(7):1049-54. PubMed ID: 26990766 [TBL] [Abstract][Full Text] [Related]
16. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. Parkinson Study Group JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889 [TBL] [Abstract][Full Text] [Related]